Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (9839)	10/21/1997 3:00:00 AM
From: CYBERKEN	Read Replies (1) \| Respond to of 32384

Please expand a little on your comment that you're pretty sure which Lily drug Ligand wants. I got the impression that there were several choices and that Ligand might need up to 90 days to decide. But if Ligand already knows their choice, it's hard to believe that Lily doesn't. Therefore why not just plug it into the deal and the resulting releases? We can all assume it's not just some coffee cans of Optro left over from the Somatagen affair (Lily at it's WORST, BTW), so who's the secret being kept from? The public? Analyists? SI? Or is there really a choice still to make? Hard to believe they are just having a little fun. That's OUR job!